|
WO2016077078A1
|
|
Diagnosis and treatment of genetic alterations associated with eosinophilic esophagitis
|
|
WO2016065254A1
|
|
Compositions and methods for cartilage replacement
|
|
WO2016028879A1
|
|
Compositions and methods for modulating immune response
|
|
WO2015168072A1
|
|
System and method for local delivery of therapeutic compounds
|
|
WO2015095636A2
|
|
Interferon regulatory factor 1 (irf1) decoys and methods of use thereof
|
|
US2015116667A1
|
|
Apparatus and methods for testing visual function and functional vision at varying luminance levels
|
|
US2016203738A1
|
|
Apparatus and method for teaching intussusception reduction
|
|
US2016123990A1
|
|
Aav vector and assay for anti-aav (adeno-associated virus) neutralizing antibodies
|
|
US2016074428A1
|
|
Compositions and methods for the treatment of human immunodeficiency virus infection
|
|
WO2014165851A1
|
|
Transient up-regulation of myc in b-cell lymphomas
|
|
WO2014145382A2
|
|
Magnetoencephalography biomarkers of gaba-b agonist drug activity in autism spectrum disorders
|
|
KR20160024841A
|
|
Scalable manufacturing process to produce recombinant lentiviral vectors in serum-free suspension cell culture system
|
|
WO2014152965A2
|
|
Schizophrenia-associated genetic loci identified in genome wide association studies and use thereof as novel therapeutic targets
|
|
CA2906695A1
|
|
Tcf7l2 variant and methods of use thereof in diagnostic and drug screening assays
|
|
WO2014160092A1
|
|
Adeno-associated virus vectors and methods of use thereof
|
|
WO2014137977A1
|
|
Magnetic targeting device with balloon
|
|
CA2896954A1
|
|
Method and apparatus for correcting auricular deformities
|
|
CA2889583A1
|
|
Affinity peptide-modified particles and targeted drug delivery methods
|
|
WO2014039799A2
|
|
Photochemical activation of surfaces for attaching biomaterial
|
|
WO2013188727A2
|
|
Pro- and codrug derivatives formed using rapidly cleavable phenolic ester bridges
|
